Century Therapeutics Inc

Research Century Therapeutics Inc (IPSC) on Bullrun: market cap USD 434.66M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIPSC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 434.66M
• Financial periodFY2025
• RevenueUSD 109.16M
• Revenue growth1556.8%
• Net income-USD 9.58M
• Free cash flow-USD 104.72M

Valuation Snapshot

latest market cap is USD 434.66M.

About Century Therapeutics Inc

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes.

Frequently asked questions

What is Century Therapeutics Inc's market cap?

Century Therapeutics Inc's market capitalization is USD 434.66M.

What does Century Therapeutics Inc do?

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.